Virios Therapeutics Statistics
Total Valuation
VIRI has a market cap or net worth of $7.13 million. The enterprise value is $4.75 million.
| Market Cap | 7.13M |
| Enterprise Value | 4.75M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VIRI has 19.26 million shares outstanding. The number of shares has increased by 5.06% in one year.
| Shares Outstanding | 19.26M |
| Shares Change (YoY) | +5.06% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 9.71% |
| Owned by Institutions (%) | 8.15% |
| Float | 16.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.66, with zero debt.
| Current Ratio | 5.66 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -127.40% and return on invested capital (ROIC) is -196.03%.
| Return on Equity (ROE) | -127.40% |
| Return on Assets (ROA) | -113.60% |
| Return on Capital (ROIC) | -196.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.27M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.21% in the last 52 weeks. The beta is 1.87, so VIRI's price volatility has been higher than the market average.
| Beta (1Y) | 1.87 |
| 52-Week Price Change | -66.21% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 38.19 |
| Average Volume (30 Days) | 299,659 |
Short Selling Information
The latest short interest is 238,529, so 1.24% of the outstanding shares have been sold short.
| Short Interest | 238,529 |
| Short Previous Month | 214,450 |
| Short % of Shares Out | 1.24% |
| Short % of Float | 1.43% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.20M |
| Pretax Income | -5.07M |
| Net Income | -5.07M |
| EBITDA | -5.07M |
| EBIT | -5.07M |
| Earnings Per Share (EPS) | -$0.26 |
Balance Sheet
The company has $2.38 million in cash and no debt, giving a net cash position of $2.38 million or $0.12 per share.
| Cash & Cash Equivalents | 2.38M |
| Total Debt | n/a |
| Net Cash | 2.38M |
| Net Cash Per Share | $0.12 |
| Equity / Book Value | 2.65M |
| Book Value Per Share | 0.14 |
| Working Capital | 2.65M |
Cash Flow
| Operating Cash Flow | -4.11M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.11M |
| FCF Per Share | -$0.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VIRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.06% |
| Shareholder Yield | -5.06% |
| Earnings Yield | -71.16% |
| FCF Yield | -57.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |